Does Opdivo have clinical trials in China?

There are many central laboratories in China that provide monitoring services for clinical trials, and in addition to a few big-name foreign-funded laboratories, there are also private independent medical laboratories that provide this service. There are two reasons why domestic clinical trials rarely use central laboratories: domestic clinical trials do not have high requirements for data quality; The cost of the central laboratory is high, and at least the cost of logistics should be considered.

Go to the clinical trial publicity platform of the Food and Drug Administration to check.

We know that Hengrui Pharmaceutical in China has it, but it will take a few years.

We now have a need for you to have a prescription.

There is a tool on the AI help, you can go to apply for it, and you can search for it.

You can go to the official website of the major tertiary hospitals in China to inquire about the drug clinical trial institutions in the departments, or you can go to the drug clinical trial institutions of the tertiary hospitals to inquire in person, and they will put recruitment advertisements in the institutions, especially in Beijing and Shanghai.

There is a dedicated clinical recruitment platform: Cancer Help.

There are many PD1 and other clinical recruitments.

Although PD1 drugs have not been introduced in China, many domestic pharmaceutical companies and R&D institutions have declared PD1 drugs, and many patients in China have already used Opdivo and Keytruda drugs through various channels.

The person is empty and thin, and the tears are red and transparent.

It is best to do genetic testing, this drug is only on the market, and it is currently useful in China, but there are still relatively few people who use it. 301 has also been used, and they are all bought from abroad or Hong Kong. It depends on the specific disease, it is approved for lung cancer, melanoma, and kidney cancer, but this targeted drug can be used by general cancer patients, and the specific effect is also different from person to person.

If you are not at ease, you can buy this drug after genetic testing, which is more expensive. It is recommended to participate in the clinical trial of PD-1 in China.

My nasopharyngeal cancer patient was diagnosed with nasopharyngeal radiotherapy necrosis in my nasopharynx due to an overdose of director Feng Linchun of the Department of Radiotherapy in May 18 301**, and the sequelae were serious. reported that Feng Linchun, director of the Department of Radiation Oncology, took the patient's life as a child's play.

This one is listed in the United States, but it is not listed in China, so it is not available for the time being.

It is a new drug from Bristol-Myers Squibb in the United States.

About 15,000 yuan in Hong Kong, you can buy it directly in Hong Kong.

Hong Kong and Hong Kong are personalized programs, and it is recommended to see an oncologist directly to listen to the doctor's medication judgment and guidance.

Opdivo Chinese name (nivolumab), is a PD1 inhibitor.

It is suitable for melanin walking, and the use should follow the guidance of the resident physician of Walt Pharmacy in Hong Kong.

Don't use it indiscriminately Thank you.

The name nivolumab is nivolumab in English, produced by BMS, which was approved by the FDA in 2015 for melanoma and non-small cell lung cancer, and subsequently approved for kidney cancer, Hodgkin lymphoma, bladder cancer, etc. At present, there are very good data in experiments on advanced gastric cancer, liver cancer, colorectal cancer, etc. In 2016, it was also approved for use by the Singapore HSA.

However, the CFDA in our country has not yet approved it.

Immunization**, Opdivo and Keytruda, the latter of which is recognized by the NCCN guidelines for lung cancer, are first-line agents for advanced non-small cell lung cancer.

Can it cure grade 2 clear cell carcinoma?